^
BIOMARKER:

NRAS mutation

i
Other names: NRAS1, HRAS1, N-Ras Protein Part 4, Neuroblastoma RAS Viral (V-Ras) Oncogene Homolog, NRAS, Neuroblastoma RAS Viral Oncogene Homolog, NRAS Proto-Oncogene, GTPase




Show legend

Include preclinical:
Melanoma
Colorectal Cancer
Acute Myelogenous Leukemia
Non Small Cell Lung Cancer
Multiple Myeloma
Myelodysplastic Syndrome
Thyroid Gland Medullary Carcinoma
Mucosal Melanoma
Cutaneous Melanoma
Pancreatic Cancer
Thyroid Gland Carcinoma
Rectal Cancer
Anaplastic Astrocytoma
Lung Non-Squamous Non-Small Cell Cancer
Chronic Myelomonocytic Leukemia
Endometrial Cancer
Childhood B Acute Lymphoblastic Leukemia
Solid Tumor
ruxolitinib
binimetinib
trametinib + ERAS-254
cabozantinib capsule
HDA + azacitidine
trametinib
regorafenib
azacitidine
AS703026
HIA + azacitidine
lenzilumab
avelumab
HL-085
selinexor
cobimetinib + RG6185
trametinib + durvalumab
KO-947
venetoclax + cobimetinib
binimetinib + ribociclib
pembrolizumab
AZD6738
KIN-2787
atezolizumab + cobimetinib
selumetinib
bevacizumab
U3-1402
cisplatin + temozolomide
cisplatin + dacarbazine
pembrolizumab + selinexor
CH4987655
PDR001 + ERAS-254
AGEN2034 + AGEN1181
cetuximab + avelumab
temozolomide + rivoceranib
gemtuzumab ozogamicin
ERAS-254
FCN-159
BVD-523
nivolumab
trametinib + palbociclib
trametinib + encorafenib
cetuximab
gilteritinib
GS-9973
venetoclax
cytarabine
venetoclax + midostaurin
venetoclax + gilteritinib
venetoclax + sorafenib
RG6185
ivosidenib
lorlatinib
decitabine
SCH772984
binimetinib + encorafenib
PHI-501
encorafenib + OKI-179
binimetinib + OKI-179
selumetinib + KRT-232
cobimetinib
BMF-219
atezolizumab + RG6185
palbociclib + binimetinib
RAF709
venetoclax + IACS-010759
LY3009120
CCT241161 + CCT196969
NBL-001 + ERAS-254
trametinib + dasatinib
ixazomib
rigosertib
palbociclib + AZD1775 + PI-103
AZD1775
XL888
AZ 628
PD-0325901
REC-4881
cetuximab + LY3009120
GDC 0879
SAB298
sotorasib + IMM-1-104
RTB101 + RAF265
cobimetinib + UNC2025
panitumumab
SBI-726
palbociclib
AN2025
UNC2025
cetuximab + BGB659
CCT241161
trametinib + GSK2126458
MP470
midostaurin
trametinib + EDHS-206
MEK inhibitor
PD1 inhibitor
VRD
SOXIRI
PD1 inhibitor + MEK inhibitor
DCAG
Immunotherapy
EGFR inhibitor
PD1 inhibitor + CTLA4 inhibitor
BRAF inhibitor + MEK inhibitor